Experienced in H1N1 Influenza

Dr. Naveen Garg

Family Medicine
99 Woodland St, 
Hartford, CT 
Experienced in H1N1 Influenza
99 Woodland St, 
Hartford, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Naveen Garg is a primary care provider, practicing in Family Medicine in Hartford, Connecticut. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of H1N1 Influenza. His top areas of expertise are H1N1 Influenza and Parainfluenza.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of H1N1 Influenza.

Specialties
Family Medicine
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

99 Woodland St, Hartford, CT 06105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: July 31, 2025
Intervention Type: Biological
Study Drug: RSVPreF3
Study Phase: Phase 3
A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
Enrollment Status: Completed
Publish Date: May 18, 2025
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
Enrollment Status: Completed
Publish Date: October 05, 2023
Intervention Type: Combination product
Study Phase: Phase 3
View 3 Less Clinical Trials

1 Total Publications

Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
Journal: PloS one
Published: December 07, 2023
Similar Doctors
Advanced in H1N1 Influenza
Dr. Deborah A. Sullivan
Family Medicine
Advanced in H1N1 Influenza
Dr. Deborah A. Sullivan
Family Medicine

Umass Memorial Medical Group Inc

78 Sutton Ave, 
Oxford, MA 
 (49.7 miles away)
508-499-1760
Languages Spoken:
English
See accepted insurances

Deborah Sullivan is a primary care provider, practicing in Family Medicine in Oxford, Massachusetts. Dr. Sullivan is rated as an Advanced provider by MediFind in the treatment of H1N1 Influenza. Her top areas of expertise are Cellulitis, Peptic Ulcer, Necrosis, and Otitis.

Advanced in H1N1 Influenza
Dr. Tassy N. Hayden
Family Medicine
Advanced in H1N1 Influenza
Dr. Tassy N. Hayden
Family Medicine

Mass General Brigham Medical Group Western Massachusetts Inc

30 Locust St, 
Northampton, MA 
 (38.6 miles away)
413-582-2441
Languages Spoken:
English
See accepted insurances

Tassy Hayden is a primary care provider, practicing in Family Medicine in Northampton, Massachusetts. Dr. Hayden is rated as an Advanced provider by MediFind in the treatment of H1N1 Influenza. Her top areas of expertise are Hospital-Acquired Pneumonia, Atypical Pneumonia, Parainfluenza Virus Type 3, and Parainfluenza.

Experienced in H1N1 Influenza
Dr. Gilberto E. Ramirez
Family Medicine | Internal Medicine
Experienced in H1N1 Influenza
Dr. Gilberto E. Ramirez
Family Medicine | Internal Medicine
699 Cottage Grove Rd, 
Bloomfield, CT 
 (3.4 miles away)
860-242-0034
Languages Spoken:
English
See accepted insurances

Gilberto Ramirez is a primary care provider, practicing in Family Medicine and Internal Medicine in Bloomfield, Connecticut. Dr. Ramirez is rated as an Advanced provider by MediFind in the treatment of H1N1 Influenza. His top areas of expertise are Peptic Ulcer, Cellulitis, Hypertension, and Familial Hypertension.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Garg's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile